The Magdi Yacoub Institute

THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE SUCH OBJECTS AND PURPOSES IN ANY PART OF THE WORLD AS ARE EXCLUSIVELY CHARITABLE IN ACCORDANCE WITH THE LAWS OF ENGLAND AND WALES AND IN PARTICULAR (BUT WITHOUT PREJUDICE TO THE GENERALITY OF THE FOREGOING) TO CARRY OUT RESEARCH INTO ALL ASPECTS OF HUMAN HEART, LUNG AND OTHER DISEASE INCLUDING PREVENTION, TREATMENT AND REHABILITATION, FOR THE BENEFIT OF THE PUBLIC, BY: (1) UNDERTAKING AND PROMOTING RESEARCH (AND MAKING THE USEFUL RESULTS THEREOF PUBLICLY AVAILABLE) IN RELATION TO CARDIAC AND TRANSPLANT SURGERY, HUMAN HEART VALVES AND TISSUE ENGINEERING, CIRCULATORY SUPPORT, IMMUNOLOGY OF HEART AND LUNG DISEASE, BIOCHEMISTRY OF HEART FAILURE, BIOLOGY OF HUMAN BLOOD VESSELS, MOLECULAR ASPECTS OF HEART DISEASE, METABOLISM OF THE HUMAN HEART AND LUNG, TRANSPLANT MEDICAL MANAGEMENT, GENETIC RESEARCH (IN ALL ITS FORMS) AND ANY OTHER MEDICAL MATTER WHICH MIGHT AFFECT AN IMPROVEMENT IN HUMAN HEALTH AND WELLBEING. (11) RELIEVING PERSONS SUFFERING FROM HEART OR OTHER DISEASES BY ENABLING TRANSPLANT AND OTHER OPERATIONS TO BE CARRIED OUT AND ASSOCIATED CARE AND TREATMENT TO BE PROVIDED AT HAREFIELD HOSPITAL OR AT SUCH OTHER SITE AS MAY BE CONVENIENT OR APPROPRIATE; (111) PROVIDING AND CONSTRUCTING AMENITIES, EQUIPMENT AND FACILITIES WITHIN THE HAREFIELD HOSPITAL SITE OR ANY LINKED ESTABLISHMENTS OR OTHER APPROPRIATE SITE OR SITES FOR THE TREATMENT AND RESEARCH INTO CARE AND RELIEF OF PERSONS SUFFERING FROM HEART OR OTHER DISEASE, WHO MAY REQUIRE OR WHO ARE TO UNDERGO OR WHO HAVE UNDERGONE TRANSPLANT OR OTHER SURGERY; AND (IV) ANY OTHER MEANS WHICH APPEAR CONVENIENT FROM TIME TO TIME.